Patent · US Active

Cripto binding molecules

US8021661B2 · kind B2 · utility

2Cited by

16References

29Claims

0Family size

Assignee

BIOGEN IDEC MA INC. · US

Inventors

Scott Glaser · San Diego, US
Herman Van Vlijmen · Mechelen, BE
Alexey A. Lugovskoy · Woburn, US
Michele Sanicola-Nadel · Winchester, US
Xiufeng Wu · San Diego, US
Ellen Garber · Cambridge, US
Jose Saldanha · Ormskirk, GB

Key dates

Filing date	Jul 3, 2007
Grant date	Sep 20, 2011
Priority date	—
Expiry date	Jan 16, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention pertains to humanized forms of an anti-CRIPTO antibody and portions thereof. In one embodiment, the variable regions of these antibodies or polypeptides comprising them (e.g., full-length antibodies or domain deleted antibodies) can be used to treat disorders, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.